Finding medicines for people with limited or no options.

Investors

Email Alerts

Sign up to receive e-mail alerts whenever Jazz Pharmaceuticals posts new information to the site.

Sign up for RSS feeds

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

Diane H. Schrick
Senior Director, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

Investors

Corporate Overview

Jazz Pharmaceuticals plc (Nasdaq: JAZZ), a global biopharmaceutical company, is dedicated to developing life-changing medicines for people with limited or no options. Our strategy is to create shareholder value by:

  • Growing sales of the existing products in our portfolio, including by identifying new growth opportunities;
  • Acquiring additional differentiated products that are on the market or product candidates that are in late-stage development; and
  • Pursuing focused development of a pipeline of post-discovery differentiated product candidates.

We have made substantial progress in the execution of our strategy. We have a diverse portfolio of products and product candidates, with a focus in the areas of sleep and hematology/oncology.